|

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

RECRUITINGSponsored by University Hospital Erlangen
Actively Recruiting
SponsorUniversity Hospital Erlangen
Started2023-01-31
Est. completion2026-12
Eligibility
Age15 Years – 25 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06642831

Summary

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

Eligibility

Age: 15 Years – 25 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Female subjects age 15-25 years
* Signed written informed consent

Exclusion Criteria:

* Less than 1 years from onset of menarche
* Use of hormonal contraceptives
* Documented ongoing pregnancy
* Major ovarian abnormalities, including subject with only one ovary, cysts and solid masses \> 2 cm as detected by transvaginal ultrasound
* Malignancy ( documented malignancy, documentation of current radiation therapy or chemotherapy in medical record)

Conditions2

CancerPolycystic Ovarian Syndrome (PCOS)

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.